QuantumDX Inks Deal To Distribute IVD Tests In China
The CEO of QuantumDX, Jonathan O’Halloran, spoke to Medtech Insight about the benefits of selling diagnostics in China and argued for a pragmatic approach to IP protection when launching in a country where counterfeiting is common.
You may also be interested in...
Medtech Multinationals Up Pace Of Localization Strategies In China
China-specific go-to-market strategies are helping global medtechs access the fast-growing medical device market in China, where localization has become the buzzword for foreign players, writes news and analysis portal Omdia.
Minute Insight: QuantumDX Launches Panel Test For Flu, COVID-19 And RSV
Medtech Insight spoke to the company’s CEO to find out what the announcement means for QPOC users, and how truly rapid point-of-care testing will aide triage.
Minute Insight: Owlstone Medical’s 'Breath Biopsy' Tech Adopted By US Military
The company will create a handheld version of its FAIMS technology, which will allow rapid testing for transmissible illnesses in combat scenarios.